IP Library Granted Patent US 8,216,218
Granted Patent B2
US 8,216,218 · App. 12/171,010 · Granted Jul 10, 2012

Treatment apparatus and methods for delivering high frequency energy across large tissue areas

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,216,218
App. No.
12/171,010
Granted
Jul 10, 2012
Kind
B2
Abstract

Apparatus and methods for treating skin conditions that deliver high frequency energy across large tissue areas. The treatment apparatus comprises a treatment tip carrying a plurality of electrodes that are switched such that fewer than all of the electrodes are concurrently energized. The treatment tip includes a cooling mechanism that cools near-surface tissue regions disposed between the skin surface and the treated tissue by cooling the respective electrode that treats each of the regions. The cooling mechanism may include a heat transfer body intervening between the electrodes and a fluid delivery member configured to discharge coolant that impinges the heat transfer body. Alternatively, the cooling mechanism may include a fluid delivery member having individually valve-controlled passages configured to discharge a dedicated stream of coolant at each of the electrodes, a thermoelectric cooler, or a closed-loop fluid delivery member.

Claims (35)

1. A method of operating a tissue treatment apparatus for treating tissue located beneath a skin surface with high frequency energy from a plurality of electrodes that are electrically isolated from each other, the method comprising:

cooling a first electrode to cool a first region of the tissue by heat transfer through the first electrode;

delivering the high frequency energy from the first electrode over a first time period to treat the cooled first region of the tissue;

cooling a second electrode during the first time period to cool a second region of the tissue by heat transfer through the second electrode;

delivering the high frequency energy from the second electrode, while cooled, over a second time period subsequent to the first time period; and

after the high frequency energy is delivered from the first electrode, cooling the first electrode during the second time period to cool the treated first region of the tissue by heat transfer through the first electrode.

2. The method of claim 1 wherein cooling the first electrode further comprises:

delivering a coolant from a first nozzle with a passage oriented to discharge the coolant at the first electrode.

3. The method of claim 1 further comprising:

cooling a third electrode during the second time period to cool a third region of the tissue by heat transfer through the third electrode.

4. The method of claim 3 further comprising:

uncoupling the first electrode from a source of the high frequency energy after the first time period concludes.

5. The method of claim 4 further comprising:

coupling the second electrode with the source of the high frequency energy after the first time period concludes.

6. A method of operating a tissue treatment apparatus for treating tissue located beneath a skin surface with high frequency energy from a plurality of electrodes that are electrically isolated from each other, the method comprising:

delivering the high frequency energy from a first electrode over a first time period to treat a first region of the tissue;

delivering the high frequency energy from a second electrode over a second time period, after the conclusion of the first time period, to treat a second region of the tissue; and

cooling the second electrode during the first time period to cool the second region of tissue by heat transfer through the second electrode.

7. The method of claim 6 further comprising:

cooling the first electrode to cool the first region of the tissue, before the first time period begins, by heat transfer through the first electrode.

8. The method of claim 6 further comprising:

cooling the first electrode during the second time period to cool the first region of the tissue after the high frequency energy is delivered.

9. The method of claim 7 wherein cooling the first electrode further comprises:

cooling the first electrode after the first time period concludes to cool the first region of the tissue by heat transfer through the first electrode.

10. The method of claim 6 wherein cooling the second electrode further comprises:

cooling the second electrode before the second time period begins to cool the second region of tissue by heat transfer through the second electrode.

11. The method of claim 6 wherein high frequency energy is not delivered from the first electrode to the first region of the tissue over the second time period.

12. The method of claim 1 wherein the first and second electrodes are disposed between a source of the cooling and the first and second regions of the tissue.

13. The method of claim 6 wherein the first and second electrodes are disposed between a source of the cooling and the first and second regions of the tissue.

14. The method of claim 1 wherein the high frequency energy delivered from the first and second electrodes provides a non-invasive tissue treatment.

15. The method of claim 6 wherein the high frequency energy delivered from the first and second electrodes provides a non-invasive tissue treatment.

16. The method of claim 1 wherein the high frequency energy delivered from the first and second electrodes provides a non-ablative tissue treatment.

17. The method of claim 6 wherein the high frequency energy delivered from the first and second electrodes provides a non-ablative tissue treatment.

18. The method of claim 1 wherein the tissue is skin tissue, and the high frequency energy is delivered through the skin surface to the skin tissue.

19. The method of claim 6 wherein the tissue is skin tissue, and the high frequency energy is delivered through the skin surface to the skin tissue.

Assignments (19)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071564/0463 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
SECURITY INTEREST Recorded Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
MERGER Recorded May 13, 2021
From: THERMAGE, INC.
To: SOLTA MEDICAL, INC.
Reel/Frame 056230/0539 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
SECURITY INTEREST Recorded Jul 18, 2016
From: SOLTA MEDICAL, INC.
To: BARCLAYS BANK PLC
Reel/Frame 039178/0970 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 27, 2014
From: SILICON VALLEY BANK
To: SOLTA MEDICAL, INC.
Reel/Frame 032126/0475 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 27, 2014
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: SOLTA MEDICAL, INC.
Reel/Frame 032126/0206 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 19, 2013
From: SOLTA MEDICAL, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031674/0546 →
SECURITY INTEREST - MEZZANINE LOAN Recorded Apr 24, 2013
From: SOLTA MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 030281/0524 →
SECURITY AGREEMENT Recorded Jun 16, 2009
From: SOLTA MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 022824/0837 →